The effect of Empagliflozin on left ventricular ejection fraction in non-diabetic patients with acute anterior ST elevation Myocardial infarction treated with primary PCI

Phase 2

Recruiting

• Conditions: Acute anterior ST elevation Myocardial infarction treated with primary PCI.; ST elevation (STEMI) myocardial infarction of anterior wall; I21.0

• Registration Number: IRCT20221227056950N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Non-Diabetic patients
Patients with ejection fraction=40
Patients with anterior ST elevation myocardial infarction
Patients undergoing primary percutaneous coronary intervention(PCI)
The possibility of patient follow up for electrocardiography
Consent to admission to the study

Exclusion Criteria

Patients who are candidates for medical therapy after angiography
Patients who are candidates for CABG after angiography
patients with a history of clinical heart failure
patients with a history of Anterior STEMI
Patients with a history of PCI on LAD

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ejection fraction of left ventricle. Timepoint: Ejection fraction of left ventricle at the beginning of the study and after 40 days of treatment. Method of measurement: Echocardioghraphy.